open access

Vol 12, No 3 (2007)
Untitled
Published online: 2007-05-01
Submitted: 2007-01-17
Get Citation

Diagnosis and treatment of human adenovirus infection following allogeneic stem cell transplantation

Arjan C. Lankester
DOI: 10.1016/S1507-1367(10)60053-3
·
Rep Pract Oncol Radiother 2007;12(3):167-169.

open access

Vol 12, No 3 (2007)
Untitled
Published online: 2007-05-01
Submitted: 2007-01-17

Abstract

Background

Human adenovirus (HAdV) infections are increasingly recognized as a frequent cause of potentially fatal infections in paediatric allogeneic stem cell transplantation (SCT) recipients.

Aim

To analyse data in the field of diagnosis and treatment of human adenovirus infection following allogeneic haematopoietic stem cell transplantation.

Materials/Methods

A review of PubMed references based on evidence-based recommendations and own experience.

Results

Incidence of HAdV infections is higher in paediatric than in adult SCT recipients, which might be related to the high exposure to HAdV at young age, while HAdV-specific immunity has still to be mounted, especially in children receiving a T-cell depleted graft and/or a graft of another than an HLA-genotypically identical related donor. In subsequent retrospective and prospective studies evidence has been provided that monitoring of serum/plasma by RQ-PCR is a sensitive tool for the recognition of patients at risk of potentially fatal infection, and that quantification of HAdV DNA is instrumental to make decisions on clinical intervention, and to accurately monitor the response to antiviral therapy. Several antiviral drugs (ribavirin and cidofovir) are being used to treat HAdV infections and variable efficacy has been reported. Reports on possible clinical efficacy of drugs are often biased, because of the heterogeneity of patients and lack of information about the level of simultaneous immune reconstitution. Data from several retrospective and prospective studies have demonstrated that lymphocyte recovery is essential for the elimination of HAdV infection.

Conclusions

Based on current knowledge, boosting of immunity by tapering of immunosuppression or infusion of lymphocytes from the donor seems to be an essential element in treatment of patients at risk of HAdV viraemia. Simultaneous analysis of lymphocyte reconstitution will further improve the identification of individuals that will require and benefit most from the immunotherapeutic interventions.

Abstract

Background

Human adenovirus (HAdV) infections are increasingly recognized as a frequent cause of potentially fatal infections in paediatric allogeneic stem cell transplantation (SCT) recipients.

Aim

To analyse data in the field of diagnosis and treatment of human adenovirus infection following allogeneic haematopoietic stem cell transplantation.

Materials/Methods

A review of PubMed references based on evidence-based recommendations and own experience.

Results

Incidence of HAdV infections is higher in paediatric than in adult SCT recipients, which might be related to the high exposure to HAdV at young age, while HAdV-specific immunity has still to be mounted, especially in children receiving a T-cell depleted graft and/or a graft of another than an HLA-genotypically identical related donor. In subsequent retrospective and prospective studies evidence has been provided that monitoring of serum/plasma by RQ-PCR is a sensitive tool for the recognition of patients at risk of potentially fatal infection, and that quantification of HAdV DNA is instrumental to make decisions on clinical intervention, and to accurately monitor the response to antiviral therapy. Several antiviral drugs (ribavirin and cidofovir) are being used to treat HAdV infections and variable efficacy has been reported. Reports on possible clinical efficacy of drugs are often biased, because of the heterogeneity of patients and lack of information about the level of simultaneous immune reconstitution. Data from several retrospective and prospective studies have demonstrated that lymphocyte recovery is essential for the elimination of HAdV infection.

Conclusions

Based on current knowledge, boosting of immunity by tapering of immunosuppression or infusion of lymphocytes from the donor seems to be an essential element in treatment of patients at risk of HAdV viraemia. Simultaneous analysis of lymphocyte reconstitution will further improve the identification of individuals that will require and benefit most from the immunotherapeutic interventions.

Get Citation

Keywords

human adenovirus infection; allogeneic HSCT

About this article
Title

Diagnosis and treatment of human adenovirus infection following allogeneic stem cell transplantation

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 12, No 3 (2007)

Pages

167-169

Published online

2007-05-01

DOI

10.1016/S1507-1367(10)60053-3

Bibliographic record

Rep Pract Oncol Radiother 2007;12(3):167-169.

Keywords

human adenovirus infection
allogeneic HSCT

Authors

Arjan C. Lankester

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl